(Q42495005)

1 November 2017

title

Trypanosoma cruzi infection suppresses nuclear factors that bind to specific sites on the interleukin-2 enhancer (English)

1 reference

1 November 2017

0 references

0 references

Soong L

1

1 reference

1 November 2017

Tarleton RL

series ordinal

2

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 January 1994

1 reference

European Journal of Immunology

1 November 2017

published in

1 reference

1 November 2017

volume

24

1 reference

1 November 2017

issue

1

1 reference

1 November 2017

page(s)

16-23

1 reference

Nuclear factor kappa B activates proenkephalin transcription in T lymphocytes

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

Interleukin-1 synergy with phosphoinositide pathway agonists for induction of interleukin-2 gene expression: molecular basis of costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

The promoter of the human interleukin-2 gene contains two octamer-binding sites and is partially activated by the expression of Oct-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

7 January 2021

Identification of a Zinc Finger Protein that Inhibits IL-2 Gene Expression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

7 January 2021

NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

7 January 2021

Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

7 January 2021

Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

7 January 2021

Evidence that interleukin-1 and phorbol esters activate NF-kappa B by different pathways: role of protein kinase C.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

7 January 2021

Changes in cell populations and immunoglobulin-producing cells in the spleens of mice infected with Trypanosoma cruzi: Correlations with parasite-specific antibody response

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

7 January 2021

Trypanosoma cruzi: Flow cytometric analysis of lymphocyte subsets in susceptible and protected C3H/He mice

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

7 January 2021

IP-1: a dominant inhibitor of Fos/Jun whose activity is modulated by phosphorylation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

7 January 2021

Nuclear factor of activated T cells contains Fos and Jun.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

7 January 2021

The AP-1 site at -150 bp, but not the NF-kappa B site, is likely to represent the major target of protein kinase C in the interleukin 2 promoter

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

7 January 2021

Identification of a putative regulator of early T cell activation genes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

7 January 2021

Transactivation by AP-1 is a molecular target of T cell clonal anergy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

7 January 2021

The immunosuppressives FK 506 and cyclosporin A inhibit the generation of protein factors binding to the two purine boxes of the interleukin 2 enhancer

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

7 January 2021

Negative regulation of interleukin 2 transcription by the glucocorticoid receptor

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

7 January 2021

The mechanism of action of cyclosporin A and FK506

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

7 January 2021

DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

7 January 2021

I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

7 January 2021

T-cell-specific expression of interleukin 2: evidence for a negative regulatory site

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

7 January 2021

A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

7 January 2021

A cell culture model for T lymphocyte clonal anergy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830240104

7 January 2021

Identifiers

DOI

10.1002/EJI.1830240104

1 reference

1 November 2017

1 reference